Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,728.50
Bid: 1,727.00
Ask: 1,728.00
Change: 23.50 (1.38%)
Spread: 1.00 (0.058%)
Open: 1,705.00
High: 1,729.50
Low: 1,695.50
Prev. Close: 1,705.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK WINNERS & LOSERS: BT Rises On EE Purchase

Thu, 05th Feb 2015 11:12

LONDON (Alliance News) - The following stocks are amongst the biggest risers and fallers within the main London indices midday Thursday.
-------
FTSE 100 WINNERS
-------
BT Group, up 4.7%. The company said it has now agreed a deal to acquire mobile network EE for GBP12.5 billion in cash and shares, a deal that will give EE's joint owners Deutsche Telekom AG and Orange SA stakes in BT. BT will pay the cash amount through a combination of new debt financing and around GBP1 billion from the placing of new BT shares. It said this placing will be launched in due course.

GlaxoSmithKline, up 1.8%. The pharmaceutical company late Wednesday said it has agreed to sell nearly 4.5 million shares in Genmab through an accelerated bookbuild. The shares are its entire 7.9% stake in the Danish business. The final offer price was set at DKK430.00 a share, meaning gross proceeds were about GBP194 million. This came after company reported a drop in pretax profit for 2014 Wednesday, hit by lower revenue for asthma and chronic obstructive pulmonary disease treatment Advair, and said that it was continuing to evaluate the possibility of an initial public offering for a minority stake in its HIV joint venture ViiV Healthcare.

Compass Group, up 1.6%. The catering and outsourcing company said it made a strong start to its new financial year, citing like-for-like revenue growth, with modest pricing and sales volume improvements in its first quarter. It said organic revenue grew by 5.7% in the three months to end-December, whilst it also improved its operating margin.

Smith & Nephew, up 1.2%. The medical devices company reported higher revenue and trading profit for 2014, although earnings per share were hit by restructuring and acquisition costs. Its trading profit rose to USD1.06 billion for the year as a whole, from USD987 million in 2013, as revenue rose to USD4.62 billion, from USD4.35 billion. Trading profit rose to USD325 million in the fourth quarter, from USD292 million a year earlier, as revenue rose to USD1.25 billion, from USD1.18 billion.
-------
FTSE 100 LOSERS
-------
AstraZeneca, down 2.0%. The pharmaceutical giant moved to further bolster its respiratory drug pipeline by acquiring the rights to Actavis' branded respiratory business in the US and Canada, as it reported lower earnings for 2014 due to increased investments it is making in accelerating its existing portfolio. AstraZeneca reported core earnings per share of USD4.28 for 2014, down 15% on the year after its fourth quarter core EPS dropped 38% to USD0.76, missing analysts' expectations of USD0.82. Revenue rose 1% on the year to USD26.10 billion for 2014 as a whole, but was down 2% in the fourth quarter to USD6.68 billion. The company suffered an exchange rate hit: revenue was up 3% for the full year and 2% in the fourth quarter at constant rates, while core EPS dropped 8% during the year and 28% in the fourth quarter at constant rates.

EasyJet, down 1.5%. The budget carrier reported flat passenger numbers in January and a slight year-on-year decline in its load factor. It said it carried 4 million passengers in January 2015, flat year-on-year, while its load factor fell by 0.3 percentage point to 85.1% from 85.4%.

Smiths Group, down 1.0%. The engineering company has been cut to Sell from Hold by Investec.

Unilever, down 0.9%. The company is trading lower after going ex-dividend, meaning new buyers no longer qualify for the latest dividend payouts.
-------
FTSE 250 LOSERS
-------
Premier Farnell, down 9.8%. The technology company said it expects to report an increase in sales for its full financial year on the back of higher sales in the fourth quarter, but said its operating margin has come under pressure due to strategic initiatives and discounting on the first Raspberry Pi model, and it expects its second-half gross margin to decline around 1 percentage point. It expects its full-year operating profit to be around GBP86-88 million.

Ocado Group, down 4.0%. The online-only grocer was cut to Sell from Hold, by Deutsche Bank.

Grainger, down 1.7%. The residential property company said its average sales prices rose in the first four months of its financial year, but said the start date for its new chairman has been delayed and said it is considering its options regarding the money it is owed from the sale of its Equity Release (Increments) Ltd business last year.

Daejan Holdings, down 1.2%. The company has gone ex-dividend.
-------
AIM ALL-SHARE WINNERS
-------
Environmental Recycling Technologies, up 24%. The company said it had granted a non-exclusive licence for its patented powder impression moulding process to Earth Enterprises Inc in the US. The licence allows for the manufacture and sale of flat sheet products within the US. Colorado-based Earth Enterprises will pay Environmental Recycling a licence and knowledge transfer fee of USD150,000 as well as an annual royalty based on the volume of products sold.

Ceramic Fuel Cells, up 18%. The company said it has received a loan-note conversion notice from Bergen Global Opportunity Fund for USD200,000 of the secured convertible loan notes issued under a March 2014 agreement, meaning it will issue 65.6 million new shares at AUD0.004 each to the fund.

AfriAg, up 18%. The company said it has won a contract to transport fresh produce farmed by Vanduzi, part of the Mozfoods (SA) business owned by the Gatsby Foundation in Mozambique. Under the contract, AfriAg will transport the produce to countries including South Africa, the UK, the Netherlands and Germany.

Avanti Communications Group, up 8.6%. The satellite data communications services provider said it has raised GBP60.6 million by issuing new shares as part of a financing that fully funds the construction and launch of the HYLAS 4 satellite and takes it through to the point when it expects to be cash flow positive.
-------
AIM ALL-SHARE LOSERS
-------
Pressure Technologies, off 25%. The high pressure engineering company told markets to revise down expectations for its current financial year in light of the recent sharp decline in the oil price. The company said it was carrying out a full review of prospects across the business after clients in the oil market started cutting capital spending in response to the oil price decline.

RapidCloud International, down 21%. The company has appointed Cindy Choo as its new finance director, effective immediately. She takes over from interim finance director Darren Hopkins and joins from Malaysia-based consultancy Perfect Advisory Sdn Bhd.

InfraStrata, down 14%. The company launched a share placing and subscription to raise GBP2.1 million, money it will use to fund working capital needs in 2015 and to fund work at the Islandmagee gas storage project in County Antrim, Northern Ireland. The company said it is proposing to place 46.0 million shares at 4 pence each with investors, while some of its directors and associated partied will subscribe for nearly 6.5 million shares at the same price.

Corero Network Security, down 13%. The security services company said it expects its loss for the year to be in line with market expectations, but said revenue for the year will be slightly lower on the back of weaker fourth quarter sales. Corero said it expects its earnings before interest, taxation, depreciation and amortisation loss for the year to December 31 to be in line with market expectations at around USD7 million, slightly wider than the USD6.2 million loss posted a year earlier.
-------

By Neil Thakrar; neilthakrar@alliancenews.com; @NeilThakrar1

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.